PBL offers a range of high-quality antibodies designed for human Type I, II, and III IFN receptors. These antibodies are essential tools for advancing IFN research, offering specificity and reproducibility.

Key Features:

-   Specificity: Precisely bind to target IFN receptors, ensuring accurate detection
-   Functional Studies: Enable blocking of IFN receptors to study downstream effects on gene expression and immune cell activation
-   Mechanistic Insights: Dissect signaling pathways activated by IFN receptors, identifying key pathways involved in immune responses